Health knowledge and news provided by doctors.

Findings To Further Define Role Of Intraocular Pressure In Glaucoma

Armen Hareyan's picture

Role Of Intraocular Pressure In Glaucoma

World Glaucoma Association recognized that elevated intraocular pressure (IOP) is the leading risk factor for glaucoma progression.

So accurate measurement of IOP plays a key role in assessing glaucoma risk and disease management. The panel's goal is to define more clearly the relationship between IOP and the optic nerve to minimize permanent damage, a leading cause of blindness worldwide.

The consensus panel, which represents 70 of the world's principal glaucoma societies, launched its consensus at the World Glaucoma Congress in Singapore. This marks the fourth consecutive annual consensus statement.

"It is vital to define clearly how IOP relates to optic nerve damage to improve patient care and to achieve consistency in glaucoma management across the globe," said Robert N. Weinreb, M.D., Past President of the WGA (formerly AIGS: Association of International Glaucoma Societies), Chair of the WGA Consensus Committee, Director of the Hamilton Glaucoma Center and Distinguished Professor of Ophthalmology at the University of California, San Diego, USA. "Our goal is to minimize glaucoma progression to preserve sight and maintain the overall quality of life of our patients."

In total, seven consensus points were evaluated to help determine how IOP should be measured and used, in order to understand better its overall role in glaucoma:

Follow eMaxHealth on YouTube, Twitter and Facebook.
Please, click to subscribe to our Youtube Channel to be notified about upcoming health and food tips.

- Determinants of IOP

- Measurement of IOP

- IOP Variation

- Epidemiology of IOP

- IOP as a risk factor for glaucoma development and progression

- Clinical trials and IOP

- Target IOP in clinical practice

The consensus report was based on more than two decades of groundbreaking research, which confirmed that IOP is a primary modifiable risk factor for glaucoma. Lowering IOP has been shown to be the only approach demonstrated to prevent and delay glaucoma progression.